BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
Clinical trial NCT05977036 · RECRUITING
Trial details
- NCT number
- NCT05977036
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-25
- Primary completion
- 2034-09-30
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.